SEC Form 4 · accession 0001192482-15-000188
Fibrocell Science, Inc. · FCSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Pernock
Officer — Chairman and CEO · Director
Period of report
May 13, 2015
Accepted (ET)
May 13, 2015 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000357097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 13, 2015 | P | 1,600 | $4.289 | A | 34,100 | D | |
| Common Stock | May 13, 2015 | P | 15,000 | $4.299 | A | 49,100 | D |
Table II — derivative securities
No Table II lines on this filing.